ACE2 and metabolic dysfunction-associated steatotic liver disease: As indicated in Figure 6, ACE2 and Ang1‐7 protein expression levels were lower (1.52‐fold and 4.93‐fold, respectively) in the NAFLD group than in the control group (p = 0.009 and < 0.0001, respectively).